Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Rosi Leichtle"'
Autor:
Beate Einsiedler, Otto Schildknecht, Torsten Kamp, Monika Ebnöther, Detlev Heydrich, Klaus Schwarz, Walter A. Wuillemin, Jeroen S. Goede, Elisabeth Kohne, Rosi Leichtle, Bettina Rath, Mathias Schmid, Jochen Roessler, Lothar Plaumann, Hannah Tamary, Hermann Heimpel
Publikováno v:
Blood. 107:334-340
Congenital dyserythropoietic anemia type I (CDA I) is a rare autosomal recessive disorder with ineffective erythropoiesis and iron overloading. More than 100 cases have been described, but with the exception of a report on a large Bedouin tribe, thes
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fe6d456b0e5bee190b8f9abd3c6d3173
https://doi.org/10.1182/blood-2005-01-0421
https://doi.org/10.1182/blood-2005-01-0421
Autor:
Sunitha N. Wickramasinghe, Klaus Schwarz, Elisabeth Kohne, Loïc Garçon, Andreas Matuschek, Jeroen S. Goede, Raffaele Renella, Rosi Leichtle, Gabriela Smoleńska-Sym, Florinda Gilsanz, Adriana Colita, Alberto Zanella, Josef Högel, Jean Delaunay, Achille Iolascon, Carlo Piscopo, Momin Ahmed, Silverio Perrotta, Hermann Heimpel, Brigitte Bader-Meunier, Juan Munoz
Publikováno v:
Europe PubMed Central
Congenital dyserythropoietic anemias (CDAs) are rare hereditary disorders characterized by ineffective erythropoiesis and striking abnormalities of erythroblast morphology. The mutated genes are known for the most frequent types, CDA I and II, but da
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7bf196ad27b7db538647a627aa9297da
http://hdl.handle.net/11588/371379
http://hdl.handle.net/11588/371379
Autor:
Heike L. Pahl, Anthony J. Bench, Elisabeth Strunck, Ursula Mohr, Steffen Klippel, Hermann Heimpel, Snezana Temerinac, Gerold Meinhardt, Martin Griesshammer, Rosi Leichtle, Anthony R. Green
Publikováno v:
Blood. 102(10)
To date, the diagnosis of polycythemia vera (PV) relies on clinical criteria. We have recently described the overexpression of a hematopoietic receptor, polycythemia rubra vera-1 (PRV-1), in patients with PV. Here, we report a quantitative reverse tr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c349bf9ae04d2c3ba27af8dfcb60a65e
https://pubmed.ncbi.nlm.nih.gov/14998918
https://pubmed.ncbi.nlm.nih.gov/14998918
Autor:
Hannes H. Heiβmeyer, Martin Redenbacher, Gertrud Saumweber, Wilhelm Gaus, Rosi Leichtle, Franz Porzsolt, Horst H. Krause, Peter Strigl, Kurt Fleischer, Brigitte Matischok, E. D. Kreuser, Sigmar Mende, G. Meuret, Volker Hiemeyer, Hermann Heimpel, Longin Buchelt
Publikováno v:
Cancer treatment reviews. 17(2-3)
The aim of this study was to evaluate the significance of response to the first two cycles of FEC (5-fluorouracil, 4-epirubicin, cyclophosphamide) in patients with advanced breast cancer. A total of 99 patients entered the study. They showed either h
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::41958ecc77e0edf35f4472baf3f0632c
https://pubmed.ncbi.nlm.nih.gov/2272044
https://pubmed.ncbi.nlm.nih.gov/2272044
Publikováno v:
Blut. 58:275-278
Nine previously untreated patients with Philadelphia chromosome-positive chronic myelocytic leukemia (CML) were treated with recombinant interferon alpha 2a (rIFN-alpha 2a) and hydroxyurea. Patients received 6 X 10(6) U rIFN-alpha 2a daily for the fi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4f945968ad71f669ef467f20cc6c1251
https://doi.org/10.1007/bf00320165
https://doi.org/10.1007/bf00320165
Autor:
Michael Schmelz, Friedrich Klumpp, Peter Strigl, Richard Knöchelmann, Renate Kloiber, Claudia Popp, Martin Redenbacher, W. Schreml, E. D. Kreuser, Wilhelm Gaus, Franz Porzsolt, Kurt Fleischer, G. Meuret, Siegmar Mende, Longin Buchelt, Volker Hiemeyer, Rosi Leichtle
Publikováno v:
Journal of Cancer Research and Clinical Oncology. 115:564-570
In a multicenter study we used a consensus protocol including more than five subsequent therapeutic steps for treatment of patients with advanced breast cancer. A total of 335 evaluable patients from 27 participating hospitals were allocated to a low
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0182923296dfc02290466020cb8ac956
https://doi.org/10.1007/bf00391359
https://doi.org/10.1007/bf00391359